LOVFF Cannara Biotech Inc Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
19:23
Jul 16
Jul 16
Buy Cannara Biotech (LOVFF/LOVE.TO) as 50% capacity expansion (12→18 grow rooms at ~$10M.
Buy Cannara Biotech (LOVFF/LOVE.TO) as 50% capacity expansion (12→18 grow rooms at ~$10M revenue / ~$3-4M EBITDA each) plus a new Curaleaf international distribution deal (~$10M/year high-margin revenue starting next month) could drive ~50% revenue growth within 1-2 years while the stock trades at only ~7x TTM EBITDA; management is accelerating room openings in response to clear demand signals.
HIGH
13:45
Jun 29
Jun 29
Buy Cannara Biotech (LOVFF/LOVE.TO): company posted its best-ever sales month in May.
Buy Cannara Biotech (LOVFF/LOVE.TO): company posted its best-ever sales month in May, achieved record Ontario market share, business recovered strongly into fiscal Q3 end, competitors are raising prices signaling rational oligopolistic market structure, and Q3 report in two weeks faces low bar vs. management's bullish tone. Fund discloses existing position.
MED
About LOVFF Analyst Coverage
Buzzberg tracks LOVFF (Cannara Biotech Inc) across 1 sources. 2 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 2 total trade ideas tracked. Latest voices: stocks_stones.